date,title,source
Nov-08-18,3 Health Care Stocks Seeing Heightened Activity After Midterms,ACCESSWIRE
Nov-08-18,Sesen Bio Reports Third Quarter 2018 Financial Results and Planned VISTA Trial Readouts,Business Wire
Dec-03-18,"Sesen Bio Appoints Drug Development Expert, Dennis Kim, M.D., MPH, as Chief Medical Officer",Business Wire
Dec-27-18,4 Healthcare Stocks That Could Test December Highs,ACCESSWIRE
Dec-27-18,Sesen Bio to Host Conference Call to Review Updated VISTA Trial Data in Non-Muscle Invasive Bladder Cancer,Business Wire
Jan-03-19,Sesen Bio Announces Positive Preliminary 12-Month Data from Registration Phase 3 VISTA Trial of Vicinium for Non-Muscle Invasive Bladder Cancer,Business Wire
Jan-18-19,"Sesen Bio, Inc. (NASDAQ:SESN): A Fundamentally Attractive Investment",Simply Wall St.
